IDS and mucopolysaccharidosis type 2: The recent report on survival and causes of death in prospective patients in the global HOS population highlights that a single cause of death is unlikely to reflect the full clinical situation in a patient with MPS II, but that ERT with idursulfase is nonetheless associated with increased survival [31].